Amira M. Nageeb

El Bohouth Street
Dokki, GZ 12622, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dual targeting of VEGFR-2 and FAK kinases by novel benzimidazole-oxadiazole hybrids: a potential approach in cancer therapy.

Dual targeting of VEGFR-2 and FAK kinases by novel benzimidazole-oxadiazole hybrids: a potential approach in cancer therapy.

Journal: RSC advances

Published: May 09, 2026

Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing.

Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: June 29, 2025

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations.

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations.

Journal: BMC chemistry

Published: October 05, 2024

Benzimidazole-dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions.

Benzimidazole-dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions.

Journal: RSC advances

Published: July 27, 2024

Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma.

Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma.

Journal: International journal of immunopathology and pharmacology

Published: April 30, 2024

Diphenyl urea-benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents.

Diphenyl urea-benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents.

Journal: Drug development research

Published: April 17, 2024

Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors.

Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors.

Journal: BMC chemistry

Published: January 30, 2024

Implications of targeted next-generation sequencing for bladder cancer: report of four cases.

Implications of targeted next-generation sequencing for bladder cancer: report of four cases.

Journal: Journal, genetic engineering & biotechnology

Published: February 25, 2021

Next generation sequencing of BRCA genes in glioblastoma multiform Egyptian patients: a pilot study.

Next generation sequencing of BRCA genes in glioblastoma multiform Egyptian patients: a pilot study.

Journal: Archives of physiology and biochemistry

Published: February 27, 2020

Clinical aspects of circulating miRNA-335 in breast cancer patients: A prospective study.

Clinical aspects of circulating miRNA-335 in breast cancer patients: A prospective study.

Journal: Journal of cellular biochemistry

Published: October 11, 2018

Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.

Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.

Journal: Cancer biomarkers : section A of Disease markers

Published: October 23, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026